Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer

Autor:	T.M. Davidson, C.L. Lebreton, A.E. Wahner Hendricksen, H.J. Atkinson, M.C. Larson, A.L. Oberg, D.M. Provencher, J.A. Glaspy, B.Y. Karlan, D.J. Slamon, G.E. Konecny, I.L. Ray-Coquard
Rok vydání:	2023
Předmět:	Oncology Obstetrics and Gynecology
Zdroj:	Gynecologic Oncology. 170:221-228
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2023.01.021
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::298eda0e38a543274bf3625b4bb68a9a https://doi.org/10.1016/j.ygyno.2023.01.021 Zobrazit plný text záznamu Full Text from ScienceDirect